Once-Daily Oral Semaglutide Versus Injectable GLP-1 RAs in People with Type 2 Diabetes Inadequately Controlled on Basal Insulin: Systematic Review and Network Meta-analysis

Introduction The relative efficacy and safety of once-daily oral semaglutide vs. injectable glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in subjects with type 2 diabetes (T2D) inadequately controlled on basal insulin were assessed using network meta-analysis (NMA). Methods A systematic lite...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Diabetes therapy 2021-05, Vol.12 (5), p.1325-1339
Hauptverfasser:	Chubb, Barrie, Gupta, Palvi, Gupta, Jatin, Nuhoho, Solomon, Kallenbach, Klaus, Orme, Michelle
Format:	Artikel
Sprache:	eng
Schlagworte:	Antidiabetics Cardiology Comparative analysis Diabetes Endocrinology GLP-1 receptor agonists Insulin Internal Medicine Medicine Medicine & Public Health Oral medication Original Research
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!